2023-11-10 | mRNAVicSeries2 | 1/4 | The RNA Platform: The Breadth of Possibility Beyond mRNA

mRNA LECTURE SERIES 2:

Due to the demand and success of the first lecture series, mRNA Victoria and BioMelbourne Network, host a second series of four lectures beginning in November 2023 for the Victorian RNA community.

These lectures present an opportunity for global leading specialists in the RNA field to share their knowledge with the local RNA community. 

The first lecture in Series 2 focuses on the RNA platform and its different modalities beyond mRNA.

RNA is an emerging global modality that promises treatments for previously ‘undruggable’ diseases. While the COVID pandemic proved the efficacy of mRNA vaccines, RNA as a platform technology has broader implications across multiple modalities such as mRNA, anti-sense oligonucleotides, short-interfering RNA, self-amplifying RNA, circular RNA and aptamers. It can also be used to encode other functional biological molecules such as monoclonal antibodies and cytokines.

This lecture provides an insight into the breadth of the RNA platform potential and the flexibility it provides to target a range of disease types.

Lecture One includes presentations from three speakers followed by a panel and Q&A discussion.

Facilitator: 

• Associate Professor Misty Jenkins AO, Laboratory Head, Immunology Division, WEHI

Speakers:

• Professor Marco Herold, Chief Executive Officer, Olivia Newton John Cancer Research Institute
• Dr Vi Wickramasinghe, Head, RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre
• Dr Christopher Wraight, CEO and Director, RAGE Biotech

   Duration: 90 mins

   Audio version included:   

   Captioning:   

   Subscription: $ 0

Please click here to view full details of this event.

The free PREVIEW will run for approximately 5 minutes.
You can watch in the full video in FULL screen mode once subscribed.

Please click on the PLAY icon to start the video preview.